Skip to main content
. 2020 Nov;8(21):1431. doi: 10.21037/atm-20-441

Table 1. Demographic and clinical characteristics of patients in different groups.

DN (n=49) Proteinuric controls (MN/MCD, n=29) P
DN alone (n=42) DN + MN (n=7) DM + MN/MCD (n=10) MN/MCD (n=19)
Age, years 45.9±11.1 53.9±9.8 58.6±9.4* 46.9±14.1 0.013
Male, n (%) 33 (78.6) 5 (71.4) 6 (60.0) 14 (73.7) 0.680
BMI, kg/m2 25.2±4.4 25.7±0.7 24.9±2.2 24.3±2.8 0.754
Diabetes duration, years 10.5±6.3 7.3±7.0 7.9±6.6 - 0.300
HbA1c, % 7.8±1.9 6.8±1.2 7.6±1.5 - 0.568
Diabetic retinopathy, n/n (%) 30/40 (75.0) 2/5 (40.0) 3/10 (30.0)* - 0.016
Hypertension, n (%) 35 (83.3) 4 (57.1) 7 (70.0) 7 (36.8)* 0.004
Systolic BP, mmHg 144.0±21.4 125.9±10.3 125.4±12.0* 127.8±15.0* 0.001
Diastolic BP, mmHg 85.7±12.7 82.0±7.9 81.2±9.1 77.2±12.1 0.082
Serum creatinine, μmol/L 128.5 (95.9–296.9) 88.6 (78.3–120.7) 77.6 (62.9–92.4)* 75.8 (62.0–95.9)* <0.001
Serum albumin, g/L 32.1±6.3 23.6±2.3* 26.0±7.8* 23.7±5.9* <0.001
Urine protein, g/24 h 5.7±3.7 8.8±4.5 4.7±3.4 6.6±5.1 0.203
Hematuria, n (%) 23(54.8) 5(71.4) 2 (20.0) 9(47.4) 0.150
Urinary NAG, U/L 39.5 (21.3–55.8) 37.0 (20.0–61.8) 37.0 (22.5–66.0) 59.0 (33.5–124.5) 0.697
Urinary α1-MG, mg/L 47.3 (17.8–115.8) 45.5 (21.2–69.4) 21.1 (8.2–43.9) 25.0 (17.9–79.9) 0.248

Data are presented as n (%), or mean ± SD or median (interquartile range). P values were estimated using ANOVA followed by Student’s t test, or Mann-Whitney rank sum test or chi-square test wherever applicable with Bonferroni correction. P values listed in the table are ANOVA comparing four groups and P<0.05 are shown in bold. P>0.05 indicates that there is no statistical significance among four groups. *, P<0.05 compared to DN. BMI, body mass index; BP, blood pressure; DN, diabetic nephropathy; DM, diabetic mellitus; MN, membranous nephropathy; MCD, minimal change disease. Normal range: HbA1c, Glycated hemoglobin: 4.0–6.0%; serum albumin: 40–55 g/L; serum creatinine: 44–133 μmol/L; urine protein: 0–0.15 g/24 h; urinary NAG, urinary N-acetyl-b-D-glucosaminidase: 0–21 U/L; urinary α1-MG, urinary α1-microglobulin: 0–12 mg/L.